Industry giant (and ex-employer) UnitedHealthGroup is taking fire from an analyst who questions the company’s ability to hold down health care costs, reserving practices, and the results of UHG’s Pacificare division. The analyst, Matthew Borsch of Goldman Sachs, is perhaps the only one on the street recommending against UHG – that said, his points are worth considering and may portend troubles for the industry as a whole.
Borsch notes:
– the Arizona Dept of Insurance recently levied its largest-ever fine ($340,000) against UHG for allegedly not responding to consumer complaints; failing to follow grievance and appeals processes; and not handling disputed payments appropriately. While those problems are not atypical of the industry, UHG was hit hard because it had been cited for similar issues earlier and failed to correct the problems.
– UHG faces another possible hit from a pending class-action suit similar to one that has been settled by Aetna and Cigna, who each paid $160 million to settle their cases. The case is in court this week.
– more troubling is UHG’s apparent problems with health care costs, which have been accelerating of late. That rise, coupled with the company’s payment of medical claims appears to have slowed recently, adds to concerns about future profitability.
While analysts’ opinions should always be viewed with caution, Borsch’s prognostications about UHG have been quite accurate in the past; his forecasts for UHG were the most accurate in the industry in 2004. And, his experience working at industry giant HealthNet probably gives him a leg up on the other erstwhile “experts”.
What does this mean to you?
If UHG stumbles due to higher medical costs, that will be a strong signal that health cost inflation remains unmanageable – and that will be very bad news indeed.
Thanks to Matt Holt’s FierceHealthcare for the lead.
Insight, analysis & opinion from Joe Paduda


